Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization
- Sponsor
- Asociación para Evitar la Ceguera en México
- Study ID
- NCT00930189
- Phase
- PHASE2/PHASE3
- Status
- Withdrawn
Conditions
- Subfoveal Choroidal Neovascularization
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- intravitreal injection of ranibizumab — DRUG
- intravitreal injection of triamcinolone — DRUG
- photodynamic therapy — PROCEDURE
Study Details
The purpose of this study is to compare the efficacy of photodynamic therapy with verteporfin (PDT) and IVTA vs triple therapy (TT) in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). The investigators designed a prospective, comparative, randomized, double blind, controlled study. 15 patients with classic subfoveal choroidal neovascularization secondary to age-related macular degeneration were randomized. Triple therapy can potentially offer a new treatment modality for choroidal neovascularization in patients with macular degeneration and other diseases.
Key Dates
- First listed
- Jun 30, 2009
- Start date
- Apr 30, 2006
- Status verified
- May 2024
- Primary completion
- Apr 30, 2006
- Completion
- Sep 30, 2006
Study Design
- Enrollment
- 0 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
The main outcome measures were visual acuity (VA)